Chitrang Shah

Chitrang brings to Mango Sciences 10+ years of cross-functional experience at the intersection of healthcare and life sciences strategy and operations. Across stints as a strategy consultant, angel investor, healthcare executive, clinical practitioner, and research scientist, Chitrang has worked with organisations across India, China, the USA, and the APAC and EMEA regions.

Prior to joining Mango Sciences, Chitrang was a Strategy Consultant with the specialised Therapeutic Area Transformation team in the Healthcare and Life Sciences Strategy practice at Monitor Deloitte. He has also worked with Max Healthcare in India as an Assistant General Manager in their coveted LEAD Program, driving operational and strategic initiatives for their tertiary care businesses. His clinical and research work during his post-graduate residency program focused on health policy (member of the core committee of Govt. of India’s National List of Essential Medicines – 2016) and HIV/AIDS research (pharmacovigilance of newer HAART regimens).

Chitrang holds a bachelor’s degree in Medicine (MBBS) from Shenyang Medical College, Shenyang, and dual post-graduate degrees – MD in Clinical Pharmacology from the AIIMS, New Delhi, and MBA in Finance from the Indian School of Business, Hyderabad.